Wuhan’s first batch of inhalation vaccine began vaccination CDC experts: only for booster immunization
On December 7, the first batch of Wuhan’s inhaled New Crown vaccine officially began. What is the effectiveness and safety of the inhalation vaccine? On December 8, experts from the Wuhan CDC answered that this vaccine is only used for booster immunization and has better safety performance among the elderly.
The new vaccine is only used for booster vaccination. Ltd, Wuhan Institute of Biological Products Co., Ltd, Beijing Kexing Zhongwei Biotechnology Co. People aged 18 years and above who have reached the age of 6 months can choose this vaccine for one dose of booster vaccination. The vaccine is not intended for primary immunization at this time.
Available evidence indicates that patients with common chronic diseases such as obesity and hypertension are at high risk of severe mortality following neocoronavirus infection and are a priority population for neocoronavirus vaccination, and no increased safety risk has been observed with the various technical routes of neocoronavirus vaccine in the chronic disease population. Considering the risks and benefits, the vaccine is not contraindicated for people with chronic diseases who have stable health status.
Are there any adverse reactions to inhaled recombinant novel coronavirus vaccine? Yang Xiaobing said that the main common adverse reactions at the vaccination site are dry mouth and oropharyngeal discomfort, while systemic adverse reactions such as headache and fever are occasionally seen, which can be relieved by drinking water and rest, and can disappear on their own after about 1-3 days. If the symptoms are serious, you should seek medical treatment and report to the doctor at the vaccination site.
The center reminds that you can practice 1-2 times on your own under the guidance of the vaccination doctor before the official vaccination. There is no risk to make up another inhalation after a failed inhalation.
Average Rating